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Abstract
Background: Biologically data-driven networks have become powerful analytical tools that handle massive,
heterogeneous datasets generated from biomedical fields. Protein-protein interaction networks can identify the
most relevant structures directly tied to biological functions. Functional enrichments can then be performed based
on these structural aspects of gene relationships for the study of channelopathies. Channelopathies refer to a
complex group of disorders resulting from dysfunctional ion channels with distinct polygenic manifestations. This
study presents a semi-automatic workflow using protein-protein interaction networks that can identify the most
relevant genes and their biological processes and pathways in channelopathies to better understand their
etiopathogenesis. In addition, the clinical manifestations that are strongly associated with these genes are also
identified as the most characteristic in this complex group of diseases.
Results: In particular, a set of nine representative disease-related genes was detected, these being the most
significant genes in relation to their roles in channelopathies. In this way we attested the implication of some
voltage-gated sodium (SCN1A, SCN2A, SCN4A, SCN4B, SCN5A, SCN9A) and potassium (KCNQ2, KCNH2) channels in
cardiovascular diseases, epilepsies, febrile seizures, headache disorders, neuromuscular, neurodegenerative diseases
or neurobehavioral manifestations. We also revealed the role of Ankyrin-G (ANK3) in the neurodegenerative and
neurobehavioral disorders as well as the implication of these genes in other systems, such as the immunological or
endocrine systems.
Conclusions: This research provides a systems biology approach to extract information from interaction networks
of gene expression. We show how large-scale computational integration of heterogeneous datasets, PPI network
analyses, functional databases and published literature may support the detection and assessment of possible
potential therapeutic targets in the disease. Applying our workflow makes it feasible to spot the most relevant
genes and unknown relationships in channelopathies and shows its potential as a first-step approach to identify
both genes and functional interactions in clinical-knowledge scenarios of target diseases.
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Methods: An initial gene pool is previously defined by searching general databases under a specific semantic
framework. From the resulting interaction network, a subset of genes are identified as the most relevant through
the workflow that includes centrality measures and other filtering and enrichment databases.
Keywords: Channelopathies, Protein-protein interaction networks, Genotype-phenotype relationships, Translational
bioinformatics, Behavioural diagnosis, Genetic diseases, Systems medicine
Background
The genetic aetiology of many complex diseases com-
prises different specific clinical symptoms and evolution.
The identification of their causal agents becomes essen-
tial for the detection of suitable targets, the management
of their diagnosis and the selection of the most adequate
therapies [1–3]. The increasing availability of large bib-
liographic data volumes lays the foundations for the
identification of these candidate genes [2, 4]. However,
the integration of all this knowledge requires under-
standing the diverse biomedical information sources
available. The extraction of data performed by valid as-
sociation procedures and the comprehensive interpret-
ation of all this current knowledge is complex. This is in
and of itself an issue of utmost importance for the pur-
pose mentioned above [4–6].
Traditional reductionist strategies that deal with this
diverse wealth of information focus on the study of par-
ticular molecules or signalling pathways that are useful
for the identification of diagnostic biomarkers. Neverthe-
less, it does not seem enough to approach all the system
complexity [2, 4]. Alternatively, interdisciplinary research
is developing new technologies and integrative computa-
tional methodologies in order to better understand path-
ogeneses [7, 8]. Some studies that use these current
integrative methodologies allow the discovery of co-
morbidities between Alzheimer’s disease and some types
of cancers [9] where genetic factors can play an import-
ant role along with other factors such as the environ-
ment, lifestyle, and drug treatments. They are also being
used to perform a genome-wide search for Autism gene
candidates [1]. These new tools are able to manage de-
ductive analyses by gaining insight into the connections
among diseases, even between those a priori not related
by the traditional bibliographic searches, which usually
tend to be subjective, time-consuming or not reprodu-
cible [10]. However, the large range of diverse new tools
created within different focuses hinders the existence of
a unique approach to or a consensus on their usage.
Thus, data extraction through ad-hoc approaches using
specific tools may again be complex, not reproducible or
subjective. In this way, network analyses and functional
annotation tools represent some of the best strategies
for objective interpretation of biomedical data and cope
with higher level of biological complexity [1–3, 11].
The identification of relevant genes is being addressed
from the global analysis of multiple interactions at dif-
ferent levels, usually employing networks as representa-
tions of the biological complex interactions underlying
clinical disorders [11–13]. A way to systematically de-
code the cellular signalling networks consists in the
identification of interactome for the detection of the
central nodes which maintain the structure and informa-
tion fluxes into the functional network [11, 14]. Despite
some limitations, protein-protein interaction (PPI) net-
works have been suitably applied to the definition of bio-
logical mechanisms by integrating PPI data with
transcriptional changes [1, 13–15]. It is evidenced that
in disease networks in which the alteration is produced
by mutations, the node or nodes mutated play a primary
role in the development of diseases and thus have a
central position in the network [16]. In the case of
multifactorial diseases, the nodes which seem to be the
causal factor could be located in the periphery. However,
the key nodes in the main biological and molecular
processes affected, i.e. potential pharmacological targets,
tend to have a central position in the network [1, 17–19].
Thus, for the identification of the most significant genes
in a disease as molecular targets there are useful software
tools of high impact [20–24]. One of them is STRING
[22], a database used to build predicted and well-known
PPI networks. The interactions in STRING are mainly
derived from automated text-mining and databases of
previous knowledge, among other resources. Other well-
known tool is Cytoscape [23], an open-source software
platform which has being designed for the purpose of
visualizing, analysing and modelling complex biological
networks and pathways.
Furthermore, in a system biology approach it is highly
important to know the biological and molecular pro-
cesses in which the complex set of genes involved play a
joint key role. Though, if the aim were to identify
pharmacological targets, it would also be mandatory to
unveil if these candidate genes could also be related with
other diseases as comorbidity [9, 25]. These annotations
and associations can be performed through traditional
bibliographic search systems, which are inefficient, sub-
jective and time consuming by hand [10], or by using
some of the highest impact tools from the large number
of platforms developed for functional annotation in
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objective, quick and reproducible ways [26]. This is the
case of DAVID [24], which has been shown to provide
an automatic comprehensive set of functional annotation
tools for biological interpretation of large gene lists as
pharmacological targets [7]. It is also very useful in
unveiling other related diseases, providing a more com-
prehensive view of the importance of treatments [9, 19].
In this regard, the aim of this study is to present a
semi-automatic workflow using PPI networks for the
identification and functional annotation of the most rele-
vant genes in diseases. This new contribution to the ex-
tant methods is based on the integration of a set of
multidimensional data from different biological levels
(genomics, transcriptomics and proteomics) in order to
analyse genetic correlations among diseases with differ-
ent clinical symptomatologies and/or clinical prognoses
(and still based on similar molecular mechanisms). In
order to illustrate the value of this integrative approach
and demonstrate its usefulness, we applied this method-
ology to the case of channelopathies as proof-of-concept
in order to understand their most common polygenic in-
fluences, which contributes to the overall understanding
of pathomechanisms underlying these altered-channels
diseases, in how mutations can modify disease severity
[27] and to shed some light on effective treatments [19,
28, 29]. We showed that this proposed workflow is able
to mine current available databases and platforms in the
context of channelopathies.
Results
In this section, we illustrate the experimental application
of the semi-automatic workflow (Fig. 1) to the case of
channelopathies.
Semi-automatic workflow applied to channelopathies
Gene dataset of the disease under study
First, the gene dataset of channelopathies was created by
introducing the term “channelopathies” in the first stage
of the present workflow (Fig. 1 Stage 1), which generated
a list of 42 genes involved in this complex group of
disorders: SCN5A, KCNH2, KCNQ1, HLA-B, RYR2,
SCN2A, SCN4A, CACNA1C, KCNE1, KCNE2, CACN
A1S, ATP8B4, DCHS1, SCN4B, SCN2B, SCN9A, SNTA1,
CDKL5, STK11, STXBP1, TGFB1, TGFB2, TRPC4,
SCN1A, SCN1B, HLA-DRB5, HSPB2, KCNQ2, LOXL2,
CNGB3, SCN3B, PCDH19, KCNE3, AKAP9, PRRT2,
CLCN1, ASB10, ARX, DMPK, SPESP1, ANK3, HLA-A.
Identification of the most relevant genes
Then, the list of gene names was the input for Stage 2
(Fig. 1. Stage 2). Our target organism was H. sapiens, and
a PPI network was generated through the STRING data-
base (interactome network presented in Additional file 1)
and then analysed by the Cytoscape platform (Fig. 2). We
employed the main features used as centrality parameters,
degree and betweenness (as described in methods) for the
identification of the most important vertices within the
Fig. 1 Semi-automatic workflow for the identification and functional annotation of the most relevant genes in a pathology. Stage 1) Phenopedia
[30] is a disease-centered view of genetic association studies summarized in the online Human Genome Epidemiology (HuGE) encyclopedia. It
provides a list of genes involved in the disease of interest. It is in this stage that a complex disease, a set of diseases or a certain disease can be
chosen to be studied. Stage 2) STRING [22] is a database of known and predicted protein-protein interactions that allows the discovery of
relationships across disease genotype and thus the creation of the PPI network. Cytoscape [23] is an open source software platform for the
visualization and analysis of complex networks that measures each gene and identifies network nodes. Stage 3) DAVID database [24] works as a
semi-automatic functional annotation tool of the genes obtained after Stage 2
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graph. Thus, starting from 42 genes involved in chan-
nelopathies, nine genes with the highest degree of interac-
tions and betweenness in their gene expressions were
stemmed as the most relevant in channelopathies: SCN9A,
ANK3, SCN5A, SCN2A, KCNQ2, SCN1A, KCNH2,
SCN4B and SCN4A. This same set of nine relevant genes
was also obtained using other connectivity features, such
as closeness, EigenVector and radiality (Fig. 3). The result
proves to be robust and concordant with that from Stage
2 of the workflow using only betweenness and centrality.
Gene functional annotation
Finally, the functional annotation of each gene was auto-
matically generated in Stage 3 using DAVID search tool
(Fig. 1. Stage 3). All the functional annotation results are
detailed in section 4.1 in Additional file 4.
Validation of the workflow
To measure the quality of the results obtained, we car-
ried out an alternative more conventional search with a
view to comparing the workflow annotation results to
the results offered by two other widespread family of
bibliographic methods, such as systematic review and
exhaustive review.
Comparison criterion
Using “MeSH” ontology [33], we selected four upper-
level categories with their corresponding lower-level
ones. Each of these lower-level categories refers to one
or more diseases linked to these genes. We used “health
disorder” as the specific comparator which contains up
to four upper-level categories: 1) cardiovascular diseases,
2) nervous system diseases, 3) mental diseases, and 4)
other diseases. This frame comprises all the phenotypes
Fig. 2 Protein-protein interaction (PPI) network of channelopathies analysed in Stage 2. Each network node represents the protein produced by
each single, protein-coding gene locus from the gene dataset of channelopathies. The representation is a circular layout based on the
betweenness attribute with undirected edges (other layouts shown in Additional file 10). The node size marks the level of degree and therefore
neighbourhood (the larger nodes represent proteins with a higher number of interactions). The node colour shows the level of betweenness and
therefore the level of centrality (the warmer the colour of the protein, the shorter path between the two which indicates how important the
node is within the wider context of the entire network) [31]. HLA proteins are discarded due to their disconnection from the principal
component. The image was generated by Cytoscape [23]
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of each relevant gene in channelopathies to facilitate the
visualization and comparison of functional annotation
results (as specified in Table 1). In Additional file 3 we
can find the “MeSH”-based terminological hierarchies of
the selection of the lower-level categories.
From the functional annotation results through the
last stage of the proposed workflow (using DAVID)
(Table 4.1.8 in Additional file 4) and applying “health
disorder” as the specific-domain category, we obtained
the results (consigned in Table 4.2.1 in Additional file 4)
that will be visually represented in the final results of
this work (Figs. 5, 6 and 7).
Systematic review and exhaustive review as other
traditional search systems
In the systematic review we searched by phenotype no-
menclatures, filtered by H. sapiens as the target organism
and removed duplicate entries (Fig. 4). Finally, we
extracted nine gene entries from the OMIM and Gene da-
tabases and 32 evidences of diseases from the MedGene
database (Table 2; all the diseases extracted through the
systematic review can be found in Additional file 5).
Following the same four upper-level categories, we created
an equivalent table containing each disease or clinical
manifestation related with its corresponding genes. We
used “health disorder” as the specific-domain category and
obtained the results shown in Additional file 6. We also
compared DAVID against other phenotype-oriented data-
bases of high impact, proving again the selection of this
tool in Stage 3 (information included in Additional file 9).
As our third step, exhaustive review was performed by
using the query words “gene product nomenclature” +
“diseases” in the search box of PubMed and MEDLINE
resources, the evidence filtering being the most time-
consuming task. We took the same categories and
created an equivalent table containing each disease or
clinical manifestation related to the corresponding genes,
its “health disorder” as the specific-domain category, and
its bibliographic references (Additional file 7). While
performing this traditional review, we could also expand
the functional annotation of the most relevant genes
with further information, detailed in Additional file 8.
Representation through genotype-phenotype association
networks
From the genotype-phenotype relationships found by
the three search systems used in this work – the last
stage of the workflow (Table 4.2.1 in Additional file 4),
Fig. 3 Nine genes as the most relevant in Stage 2 using different centrality statistics. Venn diagram representing the intersections calculated
through the use of other statistics for the proposed centrality measures such as closeness, Eigenvector and radiality. The same set of genes
identified with degree and betweenness only still turned out to be the most relevant in channelopathies: SCN1A, SCN2A, SCN4A, SCN4B, SCN5A,
SCN9A, KCNH2, KCNQ2 and ANK3. Venn diagram was obtained using a free available tool provided by Ghent University [32]. All the statistics
information is included in Additional file 2
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the systematic review (Additional file 5), and the ex-
haustive review (Additional file 7) — and considering all
the categories selected for every phenotype, we repre-
sented association networks for cardiovascular diseases
(Fig. 5), nervous system diseases (Fig. 6), and mental dis-
eases and other disorders (Fig. 7).
For cardiovascular diseases, DAVID search (Fig. 5a)
found more diseases than the systematic review (Fig. 5b)
and the exhaustive review (Fig. 5c), with the exception
of a connection between the gene SCN4B and “other
heart diseases” category retrieved by the exhaustive re-
view but not by DAVID or systematic searches. This is
due to the fact that the gene product of SCN4B is an
Fig. 4 Systematic review procedure for the genes of interest through OMIM, Gene and MedGen databases
Table 2 Gene accession numbers filtered through systematic
review










Table 1 “MeSH”-based categories selected. A total of four
upper-level categories and their corresponding lower-level
categories capture all the phenotypes manifested by more than
one of these genes. We resorted to “MeSH” terminological-
based hierarchical networks that include all the phenotypes as
referred in the third column (included in Additional file 3)
Upper-level
category
Lower-level category Hierarchical network
Cardiovascular
diseases
Vascular diseases Figure 3.1 in
Additional file 3
Cardiac arrhythmias




















Other disorders Sudden death Figure 3.4 in
Additional file 3
Diabetes Mellitus type 2
Periodic paralyses
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auxiliary subunit, hence it influences but not directly
causes the disease. In fact, it has been found to be asso-
ciated with various inherited arrhythmia syndromes
(Brugada syndrome, long-QT syndrome type 3, progres-
sive cardiac conduction defect, sick sinus node syn-
drome, atrial fibrillation, and dilated cardiomyopathy)
[34]. For nervous system diseases, DAVID search (Fig. 6a)
provided many more phenotypic connections among
genes than systematic review (Fig. 6b) or exhaustive re-
view (Fig. 6c), which obtained the same amount of infor-
mation. In fact, we could observe that the only gene with
a lack of disease association is the SCN4B which, as men-
tioned above, is associated with cardiovascular diseases
only. Finally, for mental and other disorders we only found
phenotypic connections for the most relevant genes in
DAVID (Fig. 7a), but not through systematic review
(Fig. 7b) nor exhaustive review (Fig. 7c).
Discussion
In the present study, we addressed the prediction of the
most relevant genes in the context of a group of path-
ologies not necessarily homogeneous but linked by a
common term, as is the case of channelopathies. The
identification of those genes may present several short-
comings: 1) finding key genes through scientific litera-
ture might be a burdensome task due to the fuzzy and
textual nature of information, 2) completely objective
criteria are hard to define, and 3) the comparison and
validation of different search methodologies might not
be objectively carried out. To tackle limitation 1), we de-
veloped an integrative methodology using a workflow
which departs from genes linked to particular diseases.
Then we built a protein-protein interaction network
from which key genes are identified through the deter-
mination of the centrality measures. Finally, we pro-
ceeded to functionally annotate these key genes through
the application of widely used data analysis tools in the
bibliography.
Although the proposed methodology is of general
purpose, in this study it was applied to the set of
diseases termed channelopathies. In this clinical context,
our method allowed the identification of the most
relevant genes (with the highest degree of intermediation
and centrality) related to channelopathies. The products
of these genes are mostly channels of two different types,
namely voltage-gated sodium channels — SCN1A,
Fig. 5 Genotype-phenotype association network for cardiovascular diseases category. Association networks created for cardiovascular diseases
category from the evidences obtained by a) last stage of the workflow, b) systematic review and c) exhaustive review. The “MeSH”-based
categories include each pathophysiological evidence shared by two or more genes. Other heart diseases include heart arrest, cardiomyopathies,
myocardial ischemia or cardiomegaly
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SCN2A, SCN4A, SCN4B, SCN5A, and SCN9A — that are
involved in the rapid depolarisation in the cardiac conduc-
tion (Reactome ID: R-HSA-5576892, Table 4.1.6 in Add-
itional file 4), and voltage-gated potassium channels —
KCNQ2 and KCNH2 — responsible for the activation of
the voltage-gated potassium channels family in the neur-
onal system (Reactome ID: R-HSA-1296072, Table 4.1.6.
in Additional file 4) [35–37]. KCNH2 is also involved in
the rapid repolarisation of the cardiac conduction (Reac-
tome ID: R-HSA-5576890, Table 4.1.6. in Additional file
4). On the other hand, Ankyrin-G (ANK3) is a protein
which deals with the vesicle-mediated transport of the
membrane trafficking (Reactome ID: R-HSA-374562,
Table 4.1.6. in Additional file 4) and is also responsible for
linking integral membrane proteins such as the voltage-
gated sodium channel with the spectrin-based membrane
skeleton [38]. Particularly, all the genes except KCNH2
contribute to the interaction between cytoskeleton
adaptor ankyrins and a type of adhesion receptor (L1)
which inhibits the nerve growth at the neural development
pathway (Reactome ID: R-HSA-445095, Table 4.1.6. in
Additional file 4) [35, 39].
Defects in the ion channels throughout the human
body have been involved in a wide phenotypic variability
in channelopathies. This remarkable causal heterogen-
eity makes the diseases hard to classify [40]. Some re-
views deal with the categorization of channelopathies
based on the organ system with which they are mainly
associated in both clinical and pathophysiological aspects
[28, 40–43]. Other reviews opt to classify channelopa-
thies according to the ion channel proteins in order to
improve the understanding of how their specific muta-
tions can be linked to diseases [27, 44–46]. In current
reviews the implication of voltage-gated sodium chan-
nels with cardiac pathologies (such as long-QT syn-
drome and fatal arrhythmias) and epilepsies is easily
retrievable [27]. The role of some voltage-gated potas-
sium channels with cardiac pathologies (heart arrhyth-
mias, dilated cardiomyopathies), epilepsies and chronic
pain is also well studied [27]. On the contrary, we do
not know much about the clustering of Ankyrin-G at
the axonal initial segments in the nervous system with
voltage-gated sodium channels [47, 48] and some potas-
sium channels [49]. In our work we found this implica-
tion of voltage-gated sodium and potassium channels in
cardiovascular diseases (SCN2A-SCN9A-KCNH2 cluster
for vascular diseases, SCN2A-SCN5A-KCNH2 cluster
for cardiac arrhythmias and SCN5A-SCN4B-KCNH2
Fig. 6 Genotype-phenotype association network for nervous system diseases category. Association networks created for nervous system diseases
category from the evidences obtained by a) last stage of the workflow, b) systematic review and c) exhaustive review. The “MeSH”-based
categories comprise each pathophysiological evidence shared by two or more genes
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cluster for other heart diseases) (Fig. 5). We also discov-
ered a very high interconnection and participation of the
genes selected not only in epilepsies, but also in febrile sei-
zures, headache disorders, neuromuscular and neurode-
generative diseases and neurobehavioral manifestations
(Fig. 6). It is interesting to highlight that in our results the
above mentioned participation of Ankyrin-G in the
nervous system (Fig. 6) is also reflected, specifically in
neurobehavioral manifestations (ANK3-SCN5A-KCNH2
cluster) and neurodegenerative diseases (ANK3-SCN2A-
SCN4A-SCN9A cluster). Finally, our results showed the
implication of the genes obtained in other types of dis-
eases, such as tobacco use disorder, diabetes mellitus type
2 or sudden death (Fig. 7), which consequently means the
involvement of these genes in other systems, such as the
immunological system [50] or the endocrine system [40].
As discussed above, we found that these results corrobor-
ate the conclusions collected by current literature about
channelopathies, even outcomes which are not retrievable
in comparative terms with respect to other traditional lit-
erature mining.
Approaching the above-mentioned validation of the
proposed methodology by statistical comparison with
other extant methods would be difficult due to their very
different nature and properties. For that reason, we com-
pared our proposal with two traditional and widespread
family of methods, these being systematic review and ex-
haustive review. Among the three methods employed,
our workflow and the systematic review proved to be the
most objective approach when compared to the exhaust-
ive review. Our results indicate that our methodology is
actually able to find more correlations among the nine
genes selected than any of the other two methods. Par-
ticularly, the present approach allows the detection of
many more correlations than the systematic review (as
seen in Figs. 5, 6 and 7).
Therefore, the proposed methodology is able to gather
as much significant information as any other traditional
literature search system mentioned in this work. At the
same time, it was shown to work more flexibly, making
it a convenient and easy-to-perform first-level approach
compared to the above-mentioned methods.
Fig. 7 Genotype-phenotype association network for mental and other diseases categories. Association networks created for mental and other
diseases categories from the evidences obtained by a) last stage of the workflow, b) systematic review and c) exhaustive review. The “MeSH”-
based categories comprise each pathophysiological evidence shared by two or more genes. Other mental disorders include bipolar disorder,
Alzheimer disease, autism, depression or schizophrenia
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Conclusion
We showed the usefulness of a semi-automatic integra-
tive workflow with regard to successful, currently avail-
able mining databases and platforms based on protein-
protein interaction networks applied to channelopathies.
This workflow builds as productive results as a non-
automatic research but in a quicker way, functioning as
a bridge-builder among fields and allowing the extrac-
tion of information which a priori might not seem
relevant when the starting point is a very large group of
genes in disease. We encourage future line of research
to focus on the full automatization of the workflow and
the use of more specific statistical resources such as
principal component analysis or machine learning
classifiers.
Methods
In this section, we present the semi-automatic workflow
(Fig. 1) and describe the current systems biology tools
and processes used. Thus, the course of action runs as
follows: first, a gene dataset of disease under study is ex-
tracted; second, a protein-protein interaction network is
built and analysed and the most significant genes in dis-
ease are selected; third, the functional annotation for
each relevant gene is performed.
Semi-automatic workflow
Gene dataset of the disease under study
In the first step of the workflow (Fig. 1, Stage 1), the
“MeSH” term [33] of the disease at issue was obtained to
know the unequivocal medical concept and introduced
in Phenopedia [30]. Phenopedia is an online tool pro-
vided by the Center for Disease Control and Prevention
(CDC) which allows linking genomic discoveries with
health care and disease prevention. Through Phenopedia
we extracted the list of genes which have been demon-
strated to be involved in the disease so far.
Identification of the most relevant genes
The next step (Fig. 1, Stage 2) consisted in the generation of
a protein-protein interaction (PPI) network from the list of
genes through STRING [22]. We considered Homo sapiens
as the target organism and extracted the PPI network. Then,
the NetworkAnalizer available in Cytoscape [23] allows to
compute and analyse a comprehensive set of topological pa-
rameters. The most highly connected proteins with a central
role in the network are three times more likely to be essential
than those with peripheral role, while at the same time being
more associated with alterations that have a primary role in
the development of diseases [51]. The identification of rele-
vant genes in a disease has been addressed using two central-
ity parameters for the detection of the central nodes which
maintain the structure and information fluxes into the func-
tional network [17, 52, 53]. The network centrality features
considered in the proposed workflow are degree and be-
tweenness, two fundamental parameters in graph theory [17,
51–53]. Centrality degree is defined as the number of inter-
actions in which a protein is involved. Betweenness is the
number of shortest paths between all pairs of other proteins
that pass through a certain protein [52, 53]. We set a thresh-
old on both centrality parameters by their means and, after
sorting them, those gene expressions exceeding this thresh-
old were selected as the most relevant genes
(Additional file 2).
Gene functional annotation
The last stage employed DAVID search (Fig. 1 Stage 3) for
the functional annotation of genes, allowing the description
of their main biological processes and the development of a
functional enrichment analysis (providing information about
Gene Ontology, protein interactions, functional protein do-
mains, diseases associations, and signalling pathways, among
others) from a list of genes (as official gene symbols) for the
target organism Homo sapiens.
Validation of the workflow
Genotype-phenotype relationships of genes were obtained
through the classification of the pathophysiological manifes-
tations and diseases associated to the genes at issue. For the
validation of the present workflow, we mapped those
genotype-phenotype relationships of the genes obtained from
the functional annotation onto phenotypic networks. We
considered specific-domain category “health disorder” as our
choice of interest from all the functional annotation results.
This category was taken from the Medical Subject Headings
(“MeSH”), a terminological database that captures biomed-
ical information through ontological hierarchies [33]. MeSH
offers a hierarchical organization of different pathological
categories of every clinical manifestation that facilitates the
representation of genotype-phenotype relationships. The
pathophysiological implications shared by the most signifi-
cant genes can thus be easily identified by means of their
grade of intermediation and interaction.
Hence, we could compare the results of this workflow
with the clinical manifestations associated to these genes
through the use of two current traditional bibliographic
search systems, systematic and exhaustive reviews (and
other phenotype-oriented resources, Additional file 9).
We followed the guidelines of the International Union of
Pharmacology [54, 55] for the gene products nomencla-
ture. Then we created genotype-phenotype association
networks for each disease to clearly illustrate their rela-
tionships, helping visualize at a glance the different phe-
notypes found for every gene and thus to be able to
validate the efficiency in the extraction of significant in-
formation by the presented methodology. Those diseases
with no more than one gene associated were purpose-
fully omitted in the network.
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DAVID bases its disease annotation search on two
human gene databases: Online Mendelian Inheritance in
Man (OMIM, URL: /www.omim.org/) and Genetic
Association Database from complex diseases and disor-
ders (GAD DISEASE, URL: /geneticassociationdb.nih.
gov/). The systematic review was performed using data-
bases that focus on the relationships found between hu-
man genotypes and phenotypes of genetic alterations.
Web resources for data presented herein are Online
Mendelian Inheritance in Man (OMIM, URL: www.
omim.org/); Gene, which integrates information about
phenotypes and associated conditions (URL: www.ncbi.
nlm.nih.gov/gene/); and MedGene, which offers search
results about human medical genetics and conditions re-
lated to the genetic contribution (URL: www.ncbi.nlm.
nih.gov/medgen/) (Fig. 4). The exhaustive review is
sometimes an evidence-based review, more extensive
and also takes much more time and significant effort
than the systematic review, making it a tedious process
in terms of filtering and selection of information. It is
usually carried out by using a search equation with key
words defining an unspecific question of interest [10].
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12859-019-3162-1.
Additional file 1. Protein-protein interaction (PPI) network obtained
from the list of gene names involved in channelopathies. Each network
node represents the protein produced by each single, protein-coding
gene locus (Image generated by STRING). All the nodes are coloured to
show that they are the query proteins used as input for the STRING plat-
form. The nodes which are filled represent that some 3D structure is
known or predicted; empty nodes do not present any 3D structure dis-
covered as yet. The edges indicate protein-protein associations (full le-
gend available in STRING).
Additional file 2. Connectivity statistics calculated from the PPI network.
Raw statistics values of the two main centrality measures (degree and
betweenness) are considered in Stage 2 of the workflow. Other
connectivity features (closeness, Eigenvector and radiality) are included as
evidence of the efficiency of the workflow and robustness of the results.
The same nine genes identified as the most relevant are obtained from
the average calculation of all these features. This intersection was
represented in Fig. 3. HLA proteins were discarded due to their
disconnection from the principal component, as shown in Additional file
1 and Fig. 2.
Additional file 3. Description of the upper-level and lower-level cat-
egories selected for the creation of “MeSH”-based terminological net-
works. Hierarchical trees of the upper-level categories (cardiovascular
diseases, nervous system diseases, mental diseases, and other diseases)
are described in detail. Lower-level categories are based on disease evi-
dences obtained through DAVID search, systematic review and exhaust-
ive review. The categories selected for the genotype-phenotype
representations are highlighted in grey.
Additional file 4. Functional annotation results obtained through Stage
3 of the workflow. Section 1 refers to all the raw functional annotation
results of the most relevant genes in channelopathies directly extracted
from the last stage of the workflow (DAVID search). Section 2 refers to
the extraction of the diseases from this source of information. The
diseases then were classified by their lower-level categories according to
the “MeSH” criterion described in methods. Some evidences could not be
classified due to lack of enough information. These categories will allow
the visual representation of genotype-phenotype associations obtained
through DAVID search.
Additional file 5. Procedure and data extracted through the systematic
review of the most relevant genes in channelopathies. Detailed
procedure for the filtering and extraction of the relevant information of
each gene and its diseases involved in channelopathies after the
application of the systematic review.
Additional file 6. Dataset of genotype-phenotype relationships found
through systematic review of the most relevant genes in channelopa-
thies. Diseases related to the nine relevant genes through the systematic
review based on three databases (Gene, OMIM and MedGen). Each
phenotype is classified according to its MeSH category, as described in
methods.
Additional file 7. Dataset of genotype-phenotype relationships found
through exhaustive review of the most relevant genes in channelopa-
thies. Diseases linked to the nine relevant genes through the exhaustive
review. Each phenotype is classified according to its MeSH category, as
described in methods. Some evidences cannot be classified due to lack
of information.
Additional file 8. Further functional annotation results after the
exhaustive review of the most relevant genes in channelopathies.
Summary of the localization, distribution and functions of the genes after
the exhaustive review, as well as a summary of further information found
in this review. CNS: Central Nervous System; PNS: Peripheral Nervous
System; DRG: dorsal root ganglion.
Additional file 9 Quantitative validation by significance analysis of
DAVID search against other phenotype-oriented resources. We searched
the nine relevant genes resulted from the workflow in PheGenI [56],
ToppGene [57] and g:Profiler [58]. We quantitatively evaluated this search
selecting those terms with a significance less than 0.05 using Benjamini-
Hochberg FDR statistic. We obtained a minor result in DAVID search
(OMIM search did not offer the phenotypes p-values, unlike GAP DISEASE
database). Even so, results are useful to develop a quantitative compari-
son between semiautomatic platforms and bibliographic search systems
(sheet 1). From these results we represented the genotype-phenotype as-
sociation networks to compare easily each p-value phenotype obtained
(sheet 2). It should be noted that p-values of clinical phenotypes could
be only obtained from one of the two databases explored through DA-
VID (GAP DISEASE database), and so the genotype-phenotype association
network is sparser than the network of the manuscript (section A in Figs.
5, 6, 7). Yet, it is demonstrated that the workflow results are statistically
significant and are as valid as or even better than systematic or exhaust-
ive reviews. Then, we created three Boolean tables (in sheets 3, 4, 5) com-
paring each phenotype obtained from each search; these tables were
then converted to binary matrices and clustering multivariate statistical
analyses and bootstrap validations were carried out. This approach dem-
onstrated that the results provided in the manuscript, obtained from DA-
VID (DAVID_m) and systematic and exhaustive reviews, clustered
together in a robust and significant way (sheets 3, 4, 5). Hence, this work-
flow builds as productive results as a non-automatic research but in a
quicker way allowing the extraction of information which a priori might
not seem relevant when the starting point is a very large group of genes
in disease. Moreover, the results obtained using just significant FDR cor-
rected p-values also cluster in particular branches.
Additional file 10. Protein-protein interaction (PPI) network of chan-
nelopathies analysed in Stage 2 represented by other layouts. The PPI
network of channelopathies is represented as a circular layout with the
betweenness attribute (Fig. 2), or with the degree attribute in the first
page of this file. We also included this network with a hierarchical layout
in the second page of this file as other type of representation of the
same dense network. Both types of representations present each node
with undirected edges. The node size marks the level of degree and
therefore of neighbourhood (the larger nodes represent proteins with a
higher number of interactions). The node colour shows the level of be-
tweenness and therefore the level of centrality. HLA proteins are dis-
carded due to their disconnection from the principal component. The
images were generated by Cytoscape [23].
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